The Ramsay Health Care (ASX:RHC) share price has tumbled 7% this month. Is it a buy?

Is now the time to buy Ramsay shares?

The Ramsay Health Care Limited (ASX: RHC) share price has been underperforming in 2021.

Since the start of the year, the private hospital operator's shares have risen just 5.5%. This follows a 7% decline so far in November.

A male doctor wearing a white lab coat shrugs his shoulders and holds his hands up in the air looking confused.

Image source: Getty Images

Is the Ramsay share price good value now?

The subdued performance of the Ramsay share price this year has been driven by concerns over the difficult trading conditions the company is facing in Australia from lockdowns.

The good news, though, is that the team at Goldman Sachs believe this underperformance is a buying opportunity for investors.

According to a recent note, the broker has reiterated its buy rating and $74.00 price target on its shares.

Based on the current Ramsay share price of $66.20, this implies potential upside of approximately 12% for investors over the next 12 months.

Goldman is also forecasting a dividend yield of approximately 2% in FY 2022, bringing the total return on offer to ~14%.

Why does Goldman like Ramsay?

Goldman continues to highlight Ramsay as one of the more attractive recovery trades across its coverage.

It commented: "RHC's operating performance in 1Q22 was heavily impacted by various restrictions, lockdowns and other challenges associated with the pandemic. However: 1) these dynamics were widely understood (and experienced by most) prior to today; and 2) positive revenue growth (+1.3%) was ahead of our expectations given the severity of disruption during the period (widespread elective surgery bans/restrictions, isolation orders/lockdowns and infection-driven staffing shortages/procedure cancellations)."

"Despite these challenges, growth was positive in each of UK (+21%), Europe (+5%) and Asia (+15%), as the extent of volume recovery more than offset the impact of Covid-driven disruption and, whilst operating performance remains some way below pre-Covid levels, an improving trajectory is clear, and we believe the set-up for 2022 looks favourable," the broker added.

All in all, Goldman Sachs appears to believe it could be worth sticking with the Ramsay share price and sees strong returns on the horizon.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Excited group of friends watching sports on TV and celebrating.
Broker Notes

4 ASX shares tipped by brokers to return 50% to 169%

Do you own any of these ASX shares in your portfolio?

Read more »

A smiling woman puts fuel into her car at a petrol pump.
Broker Notes

2 ASX energy players that could return 20% to 30% over the next year

Global uncertainty is keeping energy prices high.

Read more »

A man sitting at his dining table looks at his laptop and ponders the share price.
Broker Notes

Buy, hold, sell: Xero, Ansell, Wesfarmers shares

Let's find out what the experts are saying about Xero and two other ASX 200 shares.

Read more »

A woman holds her finger to the side of her lips in contemplation as she looks upwards to an array of graphic images of light bulbs above her head, one of which is on and glowing.
Broker Notes

CSL, Westpac, BHP shares: Buy, hold, or sell?

Find out what the experts tip for these ASX 200 giants.

Read more »

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

Could this ASX uranium developer more than double in value?

This company's African projects are shaping up well.

Read more »

Two work colleagues looking at a laptop and discussing something.
Broker Notes

Buy, hold, sell: Wildcat Resources, Ramsay Health Care, CBA shares

The market is down on Tuesday as experts reveal insights into these three companies.

Read more »

three children wearing superhero costumes, complete with masks, pose with hands on hips wearing capes and sneakers on a running track.
Broker Notes

3 ASX small-cap shares to buy amid sector weakness: experts

The ASX Small Ords Index has tumbled 14% in 2026 vs. a 1% fall for the broader ASX All Ords.

Read more »

Excited couple celebrating success while looking at smartphone.
Broker Notes

2 ASX 300 shares tipped by brokers to return 16% to 38%

These shares could deliver market-beating returns according to analysts.

Read more »